PHAGE 1000 SR TABLET

Description

PHAGE 1000 SR TABLET is a high-strength, sustained-release (SR) oral antidiabetic medication containing Metformin Hydrochloride 1000 mg. It is primarily used for the management of Type 2 Diabetes Mellitus, especially in overweight patients when lifestyle changes such as diet and exercise alone are insufficient.

The sustained-release technology in PHAGE 1000 SR TABLET ensures gradual and consistent absorption of Metformin throughout the day, minimizing gastrointestinal side effects and improving glycemic control with once-daily dosing.

Type 2 Diabetes Mellitus (Non-insulin-dependent diabetes)
Insulin resistance in overweight or obese patients
Polycystic Ovary Syndrome (PCOS), as prescribed by physicians
Used as monotherapy or in combination with other oral antidiabetics
Decreasing hepatic glucose production
Improving insulin sensitivity
Enhancing peripheral glucose uptake
Reducing intestinal absorption of glucose

It does not cause hypoglycemia when used alone and supports weight neutrality or mild weight loss, making it a preferred first-line agent in diabetes care.

High-dose Metformin (1000 mg) with sustained-release action
Improved gastrointestinal tolerability
Effective 24-hour blood sugar control
Supports cardiovascular health and metabolic balance
Suitable for long-term diabetes management

PHAGE 1000 SR TABLET is manufactured under strict quality control in WHO-GMP, ISO, and FDA-approved facilities, ensuring consistent strength, purity, and bioavailability.

It is represented globally by BLUEPILL EXPRESS, a reliable third-party pharmaceutical manufacturer and worldwide exporter. BLUEPILL EXPRESS specializes in high-quality medicines across various therapeutic categories and serves regulated and semi-regulated markets including Europe, Asia, Africa, North America, Latin America, and the Middle East.